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ABSTRACT
Patient and public involvement and engagement has 
become an essential element of health research, ensuring 
aims and outputs are worthwhile and relevant. However, 
research involving secondary data analyses does not 
present immediately obvious ways to involve patients 
and the public. Innovative approaches to ensure their 
involvement is meaningful and effective are required.
The Cancer Survival Group cohosted a full- day meeting 
with the National Cancer Research Institute Consumer 
Forum—a group of patients and carers. This included the 
Forum’s ‘Dragons’ Den’: a small- group session in which 
their members provided insight, advice and ideas on 
current or planned research in the Cancer Survival Group.
We investigated this activity as an example of effective 
patient involvement, with the aim of developing broad 
recommendations to improve epidemiological/quantitative 
research by involving patients and carers as directly as 
possible.
In addition to quantitative data captured through evaluation 
forms completed after the event, we used semistructured 
interviews of a sample of participants to evaluate the 
effectiveness of the session and to learn lessons. The 
interviews were analysed to identify broad or recurrent 
themes and recommendations.
Feedback was overwhelmingly positive, and some impacts 
on the research projects were identified. Interviewees 
commented on overall expectations and experiences, as 
well as specifics of room layout, timing of the session, 
composition of groups, effectiveness of the facilitation and 
content of discussions.
We present a summary of our findings as a guide for other 
researchers, including recommendations for improvement 
gleaned from the interviews. The value to researchers of 
hosting and participating in such activities was clear. We 
developed recommendations that should help to improve 
future events for ourselves and for others who wish to 
conduct similar activities, which in turn may lead to more 
concrete benefits for research and patients.
INTRODUCTION
The Cancer Survival Group (CSG) at the 
London School of Hygiene & Tropical 
Medicine has actively involved patients and 
carers in its research for many years.1 As 
members of the Group’s Advisory Panels, 
they comment on research and propose 
ideas for further research or funding. In 
2017, the CSG cohosted an event with the 
National Cancer Research Institute (NCRI) 
Consumer Forum with whom we have a well- 
established relationship. This event included 
members of the Forum contributing to our 
research through discussion of our projects, 
in ‘Dragons’ Den’ style (from the well- known 
television programme), in which the patients 
or public are the ‘dragons’ to whom the 
researchers ‘pitch’ their research ideas. This 
and other forms of patient involvement are 
common in other areas of research,2–5 but 
are not often attempted by epidemiological 
researchers.6 Here, we set out the lessons 
Strengths and limitations of this study
 ► Innovative approaches for involving patients and the 
public are needed for epidemiological research to 
ensure it is meaningful and effective.
 ► This novel format of involvement has been evaluated 
to provide insight and gather recommendations for 
improvements.
 ► Comments on the room layout, session timing, com-
position of groups and effectiveness of facilitation 
led to lessons learnt that will be implemented in the 
future.
 ► Findings can be used by other researchers in a vari-
ety of areas to establish effective forums for patient 
and public involvement (PPI).
 ► More needs to be done to ensure a broader range of 
patients and the public participate in PPI activities, 
to ensure the experiences and views of all sectors of 
society are included.
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learnt, to help other researchers capitalise on the involve-
ment of patients.
What is real patient involvement?
The involvement of patients, carers and the public 
(hereafter, for brevity, we will use the term ‘patients’ or 
‘patients with cancer’ to refer to this group, which may 
include patients, carers and members of the public) in 
health research helps to ensure that the research being 
planned and the approaches undertaken to deliver it are 
relevant to their needs and interests.7–10 It also provides 
insights from the experience of people who use health 
services, or live with the condition in question. INVOLVE, 
the UK’s national advisory group for public involvement 
in research, defines it as ‘research being carried out “with” 
or “by” members of the public rather than “to”, “about” 
or “for” them’.11 12 Patients and the public can offer new 
perspectives that researchers may be unable to provide, 
and can help improve the quality of the research.7 10–12 
They also highlight the importance of making health 
research more transparent and publicly accountable, as 
well as empowering patients themselves.13
As epidemiologists, we try not to forget that each 
data point represents a person, but we need to re- ex-
amine whether we are asking the right questions of the 
data—those that are most relevant to improving the 
health and well- being of patients. Researchers who carry 
out secondary analysis of routinely collected data, rather 
than from primary data collection such as patient surveys, 
may find it challenging to involve patients more effec-
tively in their research.14–16
In this communication piece, we outline what we learnt 
from running a patient involvement activity. This was not 
intended to be a research project in itself, but we offer 
here some reflections on the experience that we hope will 
inform and benefit other researchers.
AN EXAMPLE OF PATIENT INVOLVEMENT
The CSG cohosted a 1- day symposium with the NCRI 
Consumer Forum, for over 50 external invitees including 
patients with cancer and carers. Our aim was to showcase 
the Group’s recent and current work to these guests, and 
to explain in detail how data are used in our work.
As part of the day, patients and researchers partici-
pated in an interactive session: the Dragons’ Den. Closer 
in concept to breakout workshops than to focus groups, 
the idea of the NCRI Consumer Forum’s Dragons’ Den is 
to be a collaborative event in which patients are not just 
listening to presentations, but are equal participants in a 
round- table discussion; in which there is a shared desire 
to move research forward; and during which researchers 
can learn directly from patients’ experiences and perspec-
tives to shape and improve their research.17
Consumer Forum members had chosen one of five 
groups, each of which was led by a researcher in a discus-
sion of a particular research question . These topics 
had been circulated in advance, with some of the ques-
tions the researchers wanted to explore (online supple-
mental appendix A). Following a brief presentation of 
the research area/question, the researchers asked the 
members for their input, advice and ideas around the 
planned research (figure 1). The session was followed by 
a short plenary session in which a patient representative 
from each table presented the main points discussed, 
allowing us to capture the salient points of conversations 
that had taken place at each table, and to identify any 
broader or recurrent themes that emerged on the day.
We describe the experience from this session to illustrate 
how researchers can interact effectively with patients and 
their representatives to improve research. We describe 
how the session was run, and the feedback and lessons 
we learnt. We offer recommendations for how future 
sessions could be planned, and how this technique can be 
used to make the most of opportunities for collaboration.
Set-up
A large teaching room with maximum capacity of 70 
persons was set up with five tables seating up to 10 people 
each (figure 2). On the day, 45 people attended, two- thirds 
(64%) of whom had been NCRI Consumer Forum members 
for 2 years or more. Most had expressed a preference for a 
particular topic. Those who had not were randomly assigned 
Figure 1 In the ‘Dragons’ Den’. Credit: photograph by 
Simon Callaghan Photography.
Figure 2 The Dragons’ Den session under way, showing 
the layout of the room used. Credit: photograph by Simon 
Callaghan Photography.
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to a table. Each table had a group of patients and two CSG 
researchers, one of whom acted as rapporteur. We scheduled 
40 mins for the session, followed by a 45 mins plenary session 
for feedback. These timings were based on the usual dura-
tion for Dragons’ Den sessions.
Methods for evaluating the meeting
Forum members were initially sent feedback forms within a 
week of the meeting. The researchers were asked to provide 
notes and immediate reflections. We received both positive 
and negative comments (online supplemental appendix B). 
We have attempted to go beyond the usual ‘polite’ feedback 
to understand what was good about the session, but also 
what was challenging, so that we could identify lessons that 
other researchers could implement in their interactions with 
patients.
In the second phase, semistructured interviews with five 
patients and five researchers, one from each table, were 
carried out within 6 months of the meeting (online supple-
mental appendix C). These interviews were transcribed 
verbatim and thematically analysed, along with the notes 
collected immediately after the event.
The thematic analysis of the transcripts followed the stages 
of data familiarisation, coding and theme refinement. Tran-
scripts were read, cleaned and read again by two authors 
(MM, YA). The texts were coded by individual researchers, 
who assigned a tentative theme to each meaningful phrase. 
Themes were then discussed, grouped together and recoded 
into overarching themes which are summarised below.18 19
SUMMARY OF REFLECTIONS AND FEEDBACK
The following seven themes emerged from analysis of the 
interview data: overall experience; expectations and impor-
tance of patient contribution; content of the discussion; 
composition of groups; facilitation of discussion; layout, 
including consideration of special needs; and timing.
In the following illustrative quotes, Consumer Forum 
members are coded C1–5 and researchers are coded R1–5, 
with ‘a’ and ‘b’ denoting the two researchers on each table. 
Patients with the same numbers as researchers were on the 
same table. More examples of participant responses for each 
section are in online supplemental appendix D.
Experience and content
Overall experience (what did you get out of the session?)
Reflections on the overall experience were overwhelm-
ingly positive. Both researchers and patients stated that 
the session had met or exceeded their expectations, that 
they learnt something from being part of it and that they 
would want to repeat it.
All the topics were relevant, it was well planned, rel-
evant to patients with cancer, living with and beyond 
cancer… I would like to see it repeated because I 
think it was a very fruitful event. (C3)
However, there were also some comments on difficul-
ties or limitations of the session (see online supplemental 
appendix D, box 1).
Expectations/importance of patient contribution
Both researchers and patients articulated the value of 
the contribution from members of the NCRI Consumer 
Forum. The patients and their carers felt that their input 
was valued, that they could improve the clarity of the 
research questions asked by the researchers, and help in 
considering the practicalities involved in the research.
Working together towards improving outcomes for 
patients is the best way to achieve reliable results… As 
a colleague on an equal basis everyone working side- 
by- side to discuss the research and receiving equal 
consideration it’s so important I think to provide this 
opportunity. (C3)
Although it was clear that input from the patients had 
made a concrete difference to the researchers’ work, 
some patients felt that more needed to be done to show 
them the value of their input after the event.
I don’t know that I’ve heard very much what about 
what will actually happen, what the next steps are… 
(C2)
The researchers’ responses focused on the new insights 
and perspectives that the patients had brought, including 
how it helps to remind us that there are real people repre-
sented by each data point (online supplemental appendix 
D, box 2).
Content of discussion
Inevitably, the content of the discussions varied greatly 
between groups. It was clear from the responses of both 
patients and researchers that some of the projects were 
less amenable to this format of discussion than others, for 
example, when the project was primarily about method-
ological development.
There were a few steps that the Consumers needed 
to understand before they could really answer things 
that would be useful to me…all of these concepts 
were quite tricky to grasp. (R1a)
Where there was synergy, the discussion flowed easily, 
the time seemed too short and the suggestions made 
were fruitful and well received. At other tables, it took 
longer for mutual understanding to develop, although it 
was generally reached in the end (online supplemental 
appendix D, box 3).
Organisation of groups
The final allocation saw six to eight patients at each table. 
Ultimately, 10–12 individuals participated in each group, 
including researchers, patients and, in some cases, other 
observers.
Composition of groups
Researchers and patients were generally positive about 
the size and overall composition of the groups. The size 
of each group allowed for a variety of backgrounds to be 
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represented at each table, which was viewed as beneficial 
to the discussions.
It was clear, though, that there is a happy medium for 
the number of participants that provides both diversity 
of experience and sufficient time for all participants to 
contribute to fruitful discussion.
I think it was fine. I wouldn’t put more. But less is 
maybe too… you may not achieve what you want. I 
think you need the diversity, but not too many peo-
ple. (R2a)
Due to the size and diversity of the groups in terms of 
experiences, both of cancer and its treatment, and in 
giving this kind of feedback to researchers, one researcher 
felt that time was spent at the start in order for everyone 
to ‘get on the same page’ (R4a). However, researchers and 
patients both recognised that there was a lack of diversity 
and representation of some demographic groups, because 
members of the NCRI Consumer Forum inevitably repre-
sent a subset of the population, and perhaps especially as 
the majority of those who attended had been members 
for at least 2 years (online supplemental appendix D, box 
4). NCRI Consumers are recruited in open competition, 
mainly to serve on academic research committees or 
other research groups working at a strategic level, and a 
successful applicant is required to have some prior knowl-
edge or experience of cancer research.20
Facilitation of discussion
The researcher presenting the topic at each table facil-
itated the discussions. Feedback from the patients and 
other researchers on how that role was performed was 
generally positive, but it was suggested that combining 
facilitation with explaining the research ideas and the 
main goals of the session was too much, and that an ‘inde-
pendent’ facilitator might be helpful. There was also a 
recommendation that it might be an advantage to have 
more senior moderators, who would feel more comfort-
able being directive in keeping the discussions on topic.
I think if maybe it had been a more senior person 
there…who is almost monitoring, keeping an eye on 
what’s going on, giving a helping hand if somebody 
looks a little bit adrift, they could intervene at that 
point and get things back on track for them. (C5)
One point identified for aiding facilitation was a sugges-
tion that more structure to the questions might have 
helped direct the discussions. Clarifying at the outset 
what the main point is, where contributions would help 
and which issues were in fact less important may have 
made the session more fruitful.
Given that the researcher at each table was both 
presenting the research and facilitating the discussions, 
having a separate note- taker was appreciated. Another 
suggestion was to encourage others to make notes, and 
that the inclusion of visual aids, such as whiteboards or 
flip charts, might help clarify the main issues, and focus 
and direct the discussions (online supplemental appendix 
D, box 5).
Layout and timing
Layout of the room
The impact of the layout of the room featured for both 
patients and researchers, who felt that the room was too 
small and the tables too close together. There was some 
concern that those with hearing difficulties were disad-
vantaged by the layout, and the patients, predominantly, 
felt that the discussions would have been better had the 
layout had been different.
…there were loads of tables in the one room. It was 
actually quite difficult to hear so that was frustrating 
in some ways (C2)
Some also made recommendations about having each 
group in a separate room, although others felt the ‘buzz’ 
of the room helped create a good atmosphere (online 
supplemental appendix D, box 6).
Consideration of special needs
In their feedback, the patients gave some useful comments 
regarding consideration of the special needs of their 
group. In addition to the room layout impacting those 
with hearing impairments (as above), it was suggested 
that materials should have been provided for note- taking.
Everyone having pen and paper to write things down, 
but having our own space to write things, a turn to 
speak and then write stuff down to be collected that 
might help. (C1)
They also suggested reducing the intensity and length 
of the day, especially considering the long- term health 
conditions of some of the patients, some of whom 
were still undergoing treatment (online supplemental 
appendix D, box 7).
Length of the session
The session was scheduled after the lunch break for 40 
mins, followed by a 45 mins plenary session. Given the 
length of time it took for each table to settle and begin 
the discussions, and after a few minutes of introduction 
and background to the topic by the researcher, there was 
roughly 30 mins for open dialogue.
Many comments indicated that the time was too short, 
based partly on the numbers of patients at each table, but 
mainly on the complexity of the topics being presented.
…in trying to put those objectives of my project in the 
most specific way and in lay terms, understandable 
way, I think by the time we bridge these initial difficul-
ties we run out of time. (R4a)
In a few groups it seemed that the discussions only 
made progress towards the end of the time allocated. 
Both patients and researchers commented that a substan-
tial part of the time was taken at the start of the session to 
develop a good understanding of the project and where 
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the researchers needed insight from the patients (online 
supplemental appendix D, box 8).
Summary of postevent evaluation by patients
Two- thirds (64%, 29/45) of patients responded to the 
request for evaluation immediately following the event. 
The Dragons’ Den session was rated as the most infor-
mative session of the day by patients. In fact, 86% rated 
the group session informative for their ‘personal devel-
opment as a consumer in cancer research’ at some level, 
and almost three- quarters of attendees (72%) found the 
session useful for their role as an NCRI Consumer to 
some degree (online supplemental appendix B).
Overall, hosting of each table was overall considered 
effective (‘very effective’: 9/29, 31.0%), but just under 
half of respondents found it only ‘slightly effective’ 
(13/29, 45%), with a few patients rating it neutral or 
ineffective, or exceptional. Most respondents found the 
event well organised (93%) and the venue location good 
(90%), but fewer found the room comfortable (59%).
RECOMMENDATIONS FOR THE FUTURE
The lessons learnt from this experience have helped 
inform the CSG’s interactions with patients. We hope 
they will offer guidance to other researchers who want 
to arrange similar sessions. Although the epidemiological 
and methodological research in the CSG differs from that 
on which patients are more used to being consulted (eg, 
designing clinical trials), the experience can be fruitful 
for both patients and researchers.
Suggestions for running a similar patient involvement session
Before the event
Send detailed ‘pre-work’ which has been piloted with one or two 
patients first, ideally cowritten by them
Explain each study succinctly. Outline the specific ques-
tions that the researchers wish to explore. Encourage 
patients to send questions in advance, to show the 
researchers what they might want to discuss or have 
clarified.
On the day
Ensure enough space between tables so that all can be heard
Ensure the layout is appropriate for the size of groups. 
Seating arrangements will be dependent on the available 
space, but ideally, the tables should be sufficiently well 
spaced that discussions at neighbouring tables are not a 
distraction.
While some groups may find background silence 
daunting and the buzz of conversation may help stimu-
late people to speak or make them feel more relaxed, for 
this group of experienced patients, most of whom were 
ready and willing to talk, a layout with more space would 
have been preferable. In another study that used a similar 
format of patient engagement, Hill et al3 found that they 
successfully dealt with initial issues of noise by spacing the 
tables out at future events.
We would suggest only two to three groups (tables) 
per room if possible, so they can be spread as widely as 
possible. This allows a sense of privacy and ensures that 
everyone at each table can hear and be heard.
We would recommend excluding those who are not 
directly involved in the session from the room (eg, organ-
isers, observers), as we found that these people add to the 
level of noise and can discourage openness.
Provide note-taking facilities and encourage their use
It is useful to provide pen and paper or post- it notes, and 
encourage notes to be written down that can be shared 
with the researchers during and after the session.
A whiteboard or flip chart for each group would enable 
diagrams and technical terms to be written up, so that 
suggestions can be recorded for all to see. It is a good idea 
to photograph the boards or flip charts at the end of the 
session, before they are taken down.
Allow plenty of time
If possible, take a whole day. Rather than having a one- off 
session, the day could be split into three discrete sessions, 
with breaks in between. Time can then be spent first on 
introductions, as well as allowing patients time to intro-
duce themselves and share their experiences. These all 
add to researchers’ understanding, even if they are not 
directly relevant to the questions that ultimately need to 
be answered about each project.
Second, allow a generous amount of time for the intro-
duction and initial discussion of the topic. This session 
can focus on general questions the patients might have to 
clarify the work, or arising from their ‘pre- work’. It should 
end with the researcher laying out the specific questions 
on which they would like to focus in the final discussion.
Lastly, run the Dragons’ Den session, which should 
then focus on eliciting specific advice for the researchers 
to solve the problems they may have been having with 
study design, or on how patients’ experiences could help 
improve their research question.
Have an independent facilitator for each group
While this type of activity is suitable for all researchers, 
no matter their seniority, career stage or experience of 
patient and public involvement (PPI), we recommend 
having an ‘independent’ facilitator for each group who 
is not directly involved in the research. This should be a 
senior researcher with experience of chairing meetings 
who can be diplomatic but firm, while keeping the discus-
sions focused, ensuring everyone is encouraged to speak 
and summarising the main points to check for clarity.3
After the event
Follow-up with patients
As well as the usual evaluation forms, we recommend that 
researchers send follow- up notes to participants so that 
they can add further comments after having had a chance 
to reflect. This will add to the richness of experience 
gained from the day, and use the patients’ knowledge to 
the fullest extent.
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It is also important to inform the people who have 
contributed to the research about what has happened 
as a result of their input and to let them know how the 
research has changed or developed as a result. This may 
be in the form of asking them to comment on research 
proposals based on the project discussed or in a brief 
report on its progress.
Remaining challenges
Several challenges remain. The composition of patient 
groups was not fully representative of the population of 
patients with cancer. This was also noted in a systematic 
review of PPI in cancer research,10 which found that PPI 
participants tend ‘to be well- educated female participants 
from ethnic majority groups’ (p 14). Harder- to- reach 
groups should be invited, if possible, including more 
disadvantaged patients or their carers, those of different 
ethnicities and those with language barriers, or their 
representatives. By definition, it is difficult to include 
these groups, but efforts to approach them should be 
considered. For example, if a session were focused on 
specific cancers (or other disease areas) one or two char-
ities focused on those conditions might be asked to invite 
participants.
We would also like to be able to include patients with 
more special needs. Consideration should be given to the 
support such patients would need, and how it can best be 
provided.
The CSG is fortunate to have access to numerous 
teaching rooms, but space was still an issue. In some loca-
tions, space may be even more limited. We would still 
suggest attempting a Dragons’ Den event, but perhaps for 
one or two groups at a time.
CONCLUSION
We have shared the lessons from one research group’s 
experience of engaging with patients and their carers, 
in the hope of encouraging other researchers to carry 
out this kind of consultation, while starting from a more 
informed position.
The Dragons’ Den process is extremely valuable to 
researchers engaged in all kinds of research, including 
epidemiological research based on routinely collected 
data. As well as receiving constructive advice on current 
research projects, it was also a chance for us to reconnect 
with the reason we do this research.
From the patients’ perspective, participants were keen 
to contribute to work that would inform research and 
change policy. They emphasise the need for action and 
for everyone to ‘raise their voices’ to work for easier 
access to data for epidemiological research, and to ensure 
that patients remain at the heart of all the research we do.
This event was held well before the COVID-19 
pandemic. For now, the way we run events and activities 
must change, especially if those events would include 
people in vulnerable groups, for example, those under-
going treatment for cancer. We believe that very successful 
patient involvement sessions can still be run using online 
platforms, using many of the suggestions we have made 
above.
Similar considerations of prework, group size and 
composition, facilitation, note- taking and timing will be 
useful in planning online events, and some will come 
to the fore even more. For instance, we believe that an 
experienced, independent facilitator will be particularly 
important in this setting.
Although online events can feel very different, we would 
argue that most of the same considerations are vital for 
researchers hoping to run such an event. Having to work 
remotely should not prevent us from engaging with and 
involving the patients and future patients whom we hope 
will benefit from our research.
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